News

We are very pleased to announce that the Anne Rowling Regenerative Neurology clinic (Edinburgh) have screened and randomised their first Octopus participant!  First patient joins the Octopus MS clinical trial in Edinburgh   ...

Two posters presenting aspects of the Octopus trial were exhibited at the Association of British Neurologists and Irish Institute of Clinical Neuroscience joint meeting that took place in Belfast, on 10th-12th of May 2023. One poster, presented by the UK MS Register's Prof Rod Middleton (pictured) and colleagues, discussed aspects of the Registration of Interest platform for t ...

We are pleased to announce that 2 more hospital sites have opened to recruitment for Octopus.  Anne Rowling Regenerative Neurology clinic in  Edinburgh and University hospital Southampton. Congratulations to both teams for joining Octopus.  For the Anne Rowling Regenerative Neurology clinic, the news was announced on their website.  Please also see their Twitter account for al ...

This post was authored by Susan Scott, Octopus PPI (Patient and Public Involvement) Representative, member of the Trial Management Group, and Co-Applicant on the grant that funded the trial. It was originally published in the MS Society's North Herts newsletter. Two of us patient representatives on the Octopus trial were very honoured to fly to Toronto in December to an Intern ...

Octopus has now received the approvals needed for the trial to proceed.  These are from the Health Research Authority (HRA), Medicines and Healthcare products Regulatory Agency (MHRA) and the Research Ethics Committee (REC).    The chosen treatments are Metformin and R/S Alpha Lipoic Acid. Further details are available via the MS Society.  The next steps are now to work with ...